Gene variant explains racial disparities in adverse reactions to urate-lowering drug

A multi-institutional study finds significant racial disparities in the risk that patients being treated for gout will develop a serious, sometimes life-threatening adverse reaction to the most commonly prescribed medication, a risk that closely correlates with the frequency of a gene variant previously associated with that adverse reaction.